R&D News | pharmaphorum

News

Pfizer drug reduces mortality in patients with fatal heart d...

Pfizer’s heart disease drug, tafamidis, reduces mortality rates in patients, according to the top-line results of a phase 3 trial.

News

Mature Woman Experiencing Hot Flush From Menopause

UK's KaNDy Therapeutics funds mid-stage trial of HRT 'replac...

Biotech hopes for IPO or big pharma deal to fund phase 3

News

Novartis succeeds where Roche failed with PI3K breast cancer...

Novartis published trial results showing its drug succeeded in tackling difficult to treat breast cancer with PIK3CA mutation, after other pharma giants including Roche failed and abandoned

News

AC Immune trials Alzheimer’s vaccine

Switzerland's AC Immune biopharma has begun mid-stage trials of a vaccine against Alzheimer’s disease and Abeta-related cognitive decline in Down Syndrome patients.

News

Opdivo and Keytruda approved in new lung cancer uses

The FDA has approved Merck's Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), after green-lighting Bristol-Myers Squibb’s (BMS)

News

AstraZeneca gets further approval for Tagrisso in Japan

AstraZeneca received approval from the Japanese regulator following a priority review of Tagrisso (osimertinib) as a first-line treatment of patients with positive non-small cell lung cance

Pfizer drug reduces mortality in patients with fatal heart d...

UK's KaNDy Therapeutics funds mid-stage trial of HRT 'replac...

Novartis succeeds where Roche failed with PI3K breast cancer...

AC Immune trials Alzheimer’s vaccine

Opdivo and Keytruda approved in new lung cancer uses

AstraZeneca gets further approval for Tagrisso in Japan

Clock starts ticking on UK's single patient record plan

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks